language-icon Old Web
English
Sign In
Acemap > Paper > Tu1896 TOFACITINIB IS SAFE AND EFFECTIVE AS MONOTHERAPY OR IN COMBINATION WITH BIOLOGIC THERAPY IN PATIENTS WITH CROHN'S DISEASE

Tu1896 TOFACITINIB IS SAFE AND EFFECTIVE AS MONOTHERAPY OR IN COMBINATION WITH BIOLOGIC THERAPY IN PATIENTS WITH CROHN'S DISEASE

2020 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    3
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.